Jolita Bekhof1, Roelien Reimink2, Paul L P Brand2. 1. Princess Amalia Children's Clinic, Isala klinieken, Zwolle, The Netherlands. Electronic address: j.bekhof@isala.nl. 2. Princess Amalia Children's Clinic, Isala klinieken, Zwolle, The Netherlands.
Abstract
BACKGROUND: A reliable, valid, and easy-to-use assessment of the degree of wheeze-associated dyspnoea is important to provide individualised treatment for children with acute asthma, wheeze or bronchiolitis. OBJECTIVE: To assess validity, reliability, and utility of all available paediatric dyspnoea scores. METHODS: Systematic review. We searched Pubmed, Cochrane library, National Guideline Clearinghouse, Embase and Cinahl for eligible studies. We included studies describing the development or use of a score, assessing two or more clinical symptoms and signs, for the assessment of severity of dyspnoea in an acute episode of acute asthma, wheeze or bronchiolitis in children aged 0-18 years. We assessed validity, reliability and utility of the retrieved dyspnoea scores using 15 quality criteria. RESULTS: We selected 60 articles describing 36 dyspnoea scores. Fourteen scores were judged unsuitable for clinical use, because of insufficient face validity, use of items unsuitable for children, difficult scoring system or because complex auscultative skills are needed, leaving 22 possibly useful scores. The median number of quality criteria that could be assessed was 7 (range 6-11). The median number of positively rated quality criteria was 3 (range 1-5). Although most scores were easy to use, important deficits were noted in all scores across the three methodological quality domains, in particular relating to reliability and responsiveness. CONCLUSION: None of the many dyspnoea scores has been sufficiently validated to allow for clinically meaningful use in children with acute dyspnoea or wheeze. Proper validation of existing scores is warranted to allow paediatric professionals to make a well balanced decision on the use of the dyspnoea score most suitable for their specific purpose.
BACKGROUND: A reliable, valid, and easy-to-use assessment of the degree of wheeze-associated dyspnoea is important to provide individualised treatment for children with acute asthma, wheeze or bronchiolitis. OBJECTIVE: To assess validity, reliability, and utility of all available paediatric dyspnoea scores. METHODS: Systematic review. We searched Pubmed, Cochrane library, National Guideline Clearinghouse, Embase and Cinahl for eligible studies. We included studies describing the development or use of a score, assessing two or more clinical symptoms and signs, for the assessment of severity of dyspnoea in an acute episode of acute asthma, wheeze or bronchiolitis in children aged 0-18 years. We assessed validity, reliability and utility of the retrieved dyspnoea scores using 15 quality criteria. RESULTS: We selected 60 articles describing 36 dyspnoea scores. Fourteen scores were judged unsuitable for clinical use, because of insufficient face validity, use of items unsuitable for children, difficult scoring system or because complex auscultative skills are needed, leaving 22 possibly useful scores. The median number of quality criteria that could be assessed was 7 (range 6-11). The median number of positively rated quality criteria was 3 (range 1-5). Although most scores were easy to use, important deficits were noted in all scores across the three methodological quality domains, in particular relating to reliability and responsiveness. CONCLUSION: None of the many dyspnoea scores has been sufficiently validated to allow for clinically meaningful use in children with acute dyspnoea or wheeze. Proper validation of existing scores is warranted to allow paediatric professionals to make a well balanced decision on the use of the dyspnoea score most suitable for their specific purpose.
Authors: Nidhya Navanandan; Katharine L Hamlington; Rakesh D Mistry; Stanley J Szefler; Andrew H Liu Journal: Ann Allergy Asthma Immunol Date: 2020-07-09 Impact factor: 6.347
Authors: Mary T Caserta; Xing Qiu; Brenda Tesini; Lu Wang; Amy Murphy; Anthony Corbett; David J Topham; Ann R Falsey; Jeanne Holden-Wiltse; Edward E Walsh Journal: J Infect Dis Date: 2017-03-01 Impact factor: 5.226
Authors: Michael D Johnson; Flory L Nkoy; Xiaoming Sheng; Tom Greene; Bryan L Stone; Jennifer Garvin Journal: J Asthma Date: 2016-11-10 Impact factor: 2.515
Authors: Michael Glenn O'Connor; Kathleen Berg; Lawrence B Stack; Donald H Arnold Journal: Ann Allergy Asthma Immunol Date: 2015-07-09 Impact factor: 6.347